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Herpesvirus saimiri (HVS) is a nonhuman primate gamma herpesvirus which can immortalize human T lymphocytes similar
to Epstein–Barr virus immortalization of B cells. The HVS-immortalized T cell lines can be cloned and they remain functional,
including susceptibility of CD4 expressing T cells to infection with human immunodeficiency virus type 1 (HIV-1). In this
report, we have used five such HVS-transformed CD4-positive T cell clones to reevaluate the role of endogenous interferon
gamma (IFNg) in HIV-1 replication in T cells. All five clones had similar phenotypes; and four clones constitutively produced
IFNg and one clone did not. All five clones could be efficiently infected with HIV-1. HIV-1 infection of the IFNg-positive
cells also upregulated IFNg mRNA production and IFNg secretion but not production of IL-2 or IL-4. In contrast, infection
of IFNg-negative cells did not induce IFNg, IL-2, or IL-4. Exposure to anti-IFNg antibodies after HIV-1 infection significantly
reduced virus production and inhibited virus-induced death of IFNg-positive cells but had no effect on IFNg-negative cells.
We conclude that in CD4-positive T lymphocytes immortalized by HVS endogenous IFNg does not inhibit HIV-1 but enhances
HIV-1 replication and cytolysis. The potential augmenting effects of IFNg on HIV-1 replication in CD4-positive T cells
recommend caution in a therapeutic use of this cytokine in AIDS. q 1997 Academic Press
INTRODUCTION 1993), and B cell help (Del Prete et al., 1994; Saha et
al., 1996). In contrast to the majority of the CD4-positive
The ability of Epstein– Barr virus (EBV) to immortalize
human T cell lines of tumor origin, CD4-bearing T-LCLs
efficiently human B lymphocytes in vitro has been very
are susceptible to highly productive infection with both
useful in studies on B cell biology, cell transforming func-
laboratory and primary strains of HIV-1 and HIV-2 (Nick
tion of EBV, and lymphomagenesis (reviewed by Kieff
et al., 1993). Thus, HVS-immortalized T-LCLs mimic in
and Liebowitz, 1990). Until recently, no similarly efficient
many respects normal T lymphocytes and they can be
approach existed for the immortalization of human T lym-
used for studies of T cell biology and function in long-
phocytes. In 1992, Biesinger et al. (1992) demonstrated
living clonal T cells. In the present work, we investigated
that certain strains of HVS, which, like EBV, is a member
whether such T cell clones can be used to resolve the
of gamma Herpesviruses and which causes T cell
controversial role of IFNg in HIV-1 infection in T cells.
lymphomas in New World monkeys (Roizman et al. 1990),
Cytokines play important but complex roles in AIDScan infect and transform human T lymphocytes in vitro.
pathogenesis (Poli and Fauci, 1993; Barker et al., 1995;Like EBV-positive B-lymphoblastoid cell lines, HVS-im-
Clerici and Shearer, 1994). Progression to AIDS appearsmortalized T lymphoblastoid cell lines (T-LCLs) carry la-
to correlate with a shift from Th1 to Th2 cytokines (e.g.,tent virus and grow for extended periods of time without
there is a decrease in IFNg), but the significance of theseantigenic or mitogenic stimulation (Biesinger et al., 1992;
changes is not clear (Clerici and Shearer, 1994). Cyto-Weber et al., 1993). T-LCLs also maintain important T
kines like TNFa induce HIV-1 expression in vitro (Poli etlymphocyte functions, including functional receptors for
al., 1990; Tadmori et al., 1991), while IFNa2 inhibits virusantigen, signal transduction through TCR, CD3, CD4, or
production (Brinchman et al., 1991). The Th1 cytokineIL-2 receptors (Broker et al., 1993; Del Prete et al., 1994;
IFNg has dichotomous effects on HIV-1 replication inMitrucker et al., 1993; Saha et al., 1996; Weber et al.,
macrophages and T cells, the two main target cells for
HIV-1 infection (Poli and Fauci, 1993). While IFNg pro-
tects primary macrophages and monocytic cell lines1 To whom correspondence and reprint requests should be ad-
dressed at Molecular Virology Laboratory St. Luke’s-Roosevelt Hospital against HIV-1 infection (Fan et al., 1994; Dhawan et al.,
Center, Columbia University, 432 W. 58th St. (Room 709), New York,
1994; Hammer et al., 1986), its effect on HIV-1 infectionNY 10019. Fax: (212) 582-5027.
of T cells varies from enhancement (Kinter et al., 1995;2 Present address: Institute for Gene Therapy and Molecular Medi-
cine, Mt. Sinai School of Medicine, New York, NY 10029. Vyakaram et al., 1990) to inhibition (Wong et al., 1988),
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with several studies showing little or no effect (Yama- nated by R. C. Gallo and was propagated and titered by the
reverse transcriptase (RT) activity in H9 cells as describedmoto et al., 1986; Hartshorn et al., 1987). The inconsistent
effects of IFNg on HIV-1 replication in T cells can be (Popovic et al., 1984).
attributed to the experimental systems used, which in
HIV-1 infectionmost cases included unfractionated PBMC rather than
isolated CD4-positive T lymphocytes. Other, more exten- Cells were infected by resuspending 2 1 105 cells/ml
sively studied cytokines such as TNF-a regulate HIV-1 in 1 ml of cell-free supernatant from H9/HTLV-IIIB cells
expression through both autocrine and paracrine path- containing 5 1 105 cpm of RT activity. The cells were
ways (Poli et al., 1990; Tadmori et al., 1991; Kinter et incubated for 2 hr at 377, thoroughly washed, and resus-
al., 1995), but the function of endogenous IFNg in HIV-1 pended in fresh medium at 2 1 105 cells/ml. For control,
replication in T cells is unknown. In this work, we have cells were mock-infected with a filtered, cell-free super-
employed HVS-immortalized T-LCLs as a means to ad- natant from an uninfected H9 cell culture. Anti-cytokine
dress these problems. First, we were able to clone T- or control (nonimmune) antisera were added at 5 mg/ml
LCLs to ensure the uniformity of T cell populations stud- as indicated. Viable cells were counted by trypan blue
ied. Second, to determine the role of endogenous IFNg exclusion and supernatants were collected at designated
in HIV-1 replication, we have examined HIV-1 infection days postinfection (dpi) and stored at 0707 for analysis
in phenotypically similar T cell clones which differed in of HIV-1 and cytokine production.
their expression of IFNg. We report that in this system of
long-lived CD4-positive T cell clones, endogenous IFNg RT and p24 assays
augments HIV-1 replication and facilitates cytolysis of
RT assays were performed in triplicates as previouslyinfected cells.
described (Willey et al., 1988). In brief, 5-ml samples were
added to 25 ml of a mixture containing poly(C), oligo(dG)MATERIALS AND METHODS
(Pharmacia Biotech Inc., Piscataway, NJ), MgCl2 , DTT,
Cells and viruses NP-40, NaCl, H2O, and
32P-labeled deoxyguanidine 5*-
triphosphate (Amersham Corp., Arlington Heights, IL).Establishment of HVS-immortalized CD4/ T cell clones
The mixture was incubated for 2 hr at 377 and 6-ml sam-has been described (Saha et al., 1996). Briefly, PBL were
ples were blotted onto DE81 paper, air dried, washedisolated from freshly drawn blood from HIV-1-negative do-
three times in 21 SSC, and two times in 95% ethanol.nors on Ficoll–Hypaque gradient (Sigma Chemicals, St.
The filters were dried under a heat lamp and counted inLouis, MO) and adherent cells were separated by incubation
a Beckman LS scintillation counter.on plastic tissue culture plates for 2 hr. Nonadherent cells
HIV-1 core antigen p24 was measured using HIV Agwere resuspended at 11 106 cells/ml in RPMI 1640 medium
kit (Coulter, Hialeah, FL) according to the manufacturer’ssupplemented with 10% heat-inactivated fetal calf serum, 2
instructions.mM L-glutamine, penicillin (100 units/ml), and streptomycin
(100 mg/ml) and infected with HVS at a multiplicity of infec-
Analysis of mRNA
tion of 0.1. Infected cells were cultured in bulk for 2–3 weeks
until immortalization was evident and then cloned at 0.5– Cellular RNA was isolated using a modified SDS/phe-
nol extraction method as described (Liu et al., 1994).1.0 cells/well in 96-well culture plates with irradiated alloge-
neic PBL (100,000/well). The two CD4/ T cell clones, Control or HIV-1-infected cells 3 days after infection were
washed and lysed in SDS/EDTA/Proteinase K solution.CHCD4 and KRCD4, that have been studied most exten-
sively in this report were derived from PBL of two different RNA was extracted by phenol followed by phenol/chloro-
form/isoamylalcohol, precipitated by ethanol, and dis-donors and were maintained in the absence of exogenous
IL-2 for over 1 year. Other IFNg-producing CD4/ T cell solved in DEPC-treated water. cDNA was synthesized by
incubating 2 mg of oligo dT-primed RNA, MuLV RT, andclones used in this study are MC2-5.4, MC2-11, MC3-1.2,
and DECD4; they were similarly developed from two other 1 mM dNTP (Perkin–Elmer–Cetus, Norwalk, CT) in a
final volume of 40 ml at 427 for 15 min followed by 5 minnormal donors and maintained in IL-2 (20 units/ml) con-
taining medium. Consistent with other reports (Biesinger et at 997 and 5 min at 47. The cDNA served as a template
for amplification of human IL-2, IL-4, IFNg, or HIV-1 env-al., 1992; Del Prete et al., 1994), the transformed cells carried
HVS genomes as determined by polymerase chain reaction specific sequences by PCR using commercially available
primers (Clontech, Palo Alto, CA) and according to manu-(PCR) amplification of HVS DNA (not shown) and did not
produce HVS as determined in a coculture assay (Berend facturer’s instructions. The amplifications yielded DNA
fragments of 305, 344, and 427 base pairs (bp) for IL-et al., 1993). HVS, group C, strain 488-77, was kindly pro-
vided by R. C. Desrosiers (Harvard Medical School, Boston, 2, IL-4, and IFNg, respectively. Each RNA sample was
subjected to the reverse transcription step with or withoutMA). The virus was propagated in owl monkey kidney cells
and titered by plaque assay in these cells as described RT to control for cellular DNA contamination. Plasmids
containing cytokine genes were used as positive controls(Berend et al., 1993). HIV-1 strain HTLV-IIIB was kindly do-
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TABLE 1 Antibodies
Phenotypes of CHCD4 and KRCD4 Cells a Rabbit antisera to IFNg, IL-2, and IL-4, and nonimmune
rabbit serum used as control, were obtained from Genzyme,
Surface molecule CHCD4 KRCD4
(Framingham, MA). Sera were heat inactivated at 567 for 30
min before use. Biological activities of the antibodies wereCD2 / /
CD3 / / tested on appropriate cells (Saha et al., 1996).
CD4 / /
CD8 0 0
RESULTSTCRa/b / /
CD20 0 0
Characterization of HVS-immortalized T cell clonesCD25 / /
CD69 / / The HVS-immortalized cells were characterized by sur-
HLA-DR / /
face marker analysis at various times after cloning andTCR-Vb2 / UD b
the overall phenotypes of two representative clones,
a Data from FACS analyses at various times after cell cloning. CHCD4 and KRCD4, are summarized in Table 1. Both
b UD, undetectable with the panel of anti-Vb antibodies used. clones expressed CD4 and other surface markers typical
for activated T lymphocytes, but not CD8 or CD20 (B cell
marker). Notably, CHCD4 but not KRCD4 expressed thein each amplification. Each sample also included primers
T cell receptor Vb2 chain, indicating that HVS does notfor human b-actin gene (Clontech) as internal control for
selectively immortalize T cells carrying a specific re-the presence of cellular RNA. b-actin amplicon was 838
arranged TCR-Vb chain, consistent with our previousbp. The primers used were designed to span introns to
data (Saha et al., 1996). Previous studies indicated thatminimize detection of genomic DNA (Clontech). HIV-1
HVS-immortalized human CD4-positive T-LCLs ex-RNA was detected using primers BRUV3 and BRUV5,
pressed predominantly IFNg, a Th1 cytokine, but not IL-which span the V3 loop of HIV-1 and yield a 350-bp DNA
4, a Th2 cytokine (DeCarli et al., 1993; Saha et al., 1996).fragment (Wain-Hobson et al., 1991). All PCR amplifica-
We tested CHCD4 and KRCD4 cells for the expressiontions were carried out using 0.2 mM of dNTP and 0.4
of IL-2, IL-4, and IFNg at the protein and mRNA levels.mM of each primer and 32 cycles of 45 sec at 947, 45
Significant levels of IFNg were detected in the superna-sec at 607, and 2 min at 727, followed by one cycle at
tants of CHCD4 but not KRCD4 cells (Table 2). High level727 for 7 min to permit completion of polymerization of
production of IFNg was also detected in MC2-5.4, MC2-the amplified products. The amplified products were re-
11, MC3-1.2, and DECD4 clones used in this study andsolved by electrophoresis on 1.8% agarose gels con-
in 20 other CD4/ T cell clones established in our labora-taining ethidium bromide (0.5 g/ml).
tory (not shown). Thus, KRCD4 is the only HVS-trans-
formed CD4/ T cell clone described thus far which ex-Cytokine assays
hibits IFNg-negative phenotype. Stimulation of CHCD4
Culture supernatants from uninfected or HIV-1-infected cells (TCR-Vb2) with TSST (a Vb2-specific superantigen)
cells were collected at 3 days after infection and were resulted in increased IFNg levels, indicating that the sig-
stored in aliquots at 0707. Levels of IL-4 and IFNg were
measured by ELISA using commercial kits for human
TABLE 2IL-4 (Genzyme Framingham, MA) and IFNg (BioSource
International, Camarillo, CA) according to the manufac- Expression of IL-2, IL-4, and IFNg in CHCD4 and KRCD4 Clones
turers’ directions. Levels of IL-2 were measured using before and after HIV-1 Infection
IL-2 responsive CTLL cell line as previously described
Cytokines a(Mosmann et al., 1986).
Cells Treatment IL-2 (U/ml) IL-4 (pg/ml) IFNg (pg/ml)Flow cytometry (FACS) analyses
CHCD4 None 0.01 45 10,464 { 2,390FACS analyses of T cells were performed using cell
KRCD4 None 0.01 45 15suspensions as previously described (Saha and Wong,
CHCD4 HIV-1 b 0.01 45 18,920 { 3,170
1992) using either FITC- or PE-labeled monoclonal anti- KRCD4 HIV-1 0.01 45 15
bodies to CD4 and CD8 (Sigma, St. Louis, MI); TCRa/b,
a Cytokines were measured as described under Materials and Meth-CD20, CD25 (Tac) (Becton –Dickinson, San Jose, CA); and
ods by using CTLL cell line for IL-2 and ELISA for IL-4 and IFNg. TheCD3 and HLA-DR (Coulter Corp., Hialeah, FL). TCR-Vb
detection limits were 0.01 U/ml for IL-2, 45 pg/ml for IL-4, and 15 pg/gene rearrangements were identified using a panel of
ml for IFNg. Positive and negative samples were included in all tests.
anti-Vb antibodies, including Vb2 and Vb3 (Amac Co, Results are of three separate experiments {SEM.
MA) and Vb5a, 5b, 5c, 6a, 8a, 12a, 13, and 17 (T Cell b Cells were infected with HIV-1 and supernatants were collected at
Day 3 for cytokine assay as described under Materials and Methods.Sciences, Cambridge, MA).
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tion of CHCD4 and KRCD4 cells early after infection, but to
different levels (Fig. 3). Consistent with a previous report
(Nick et al., 1993), HIV-1 infection in these cells was cyto-
pathic and most of the cells in both systems died a short
time after reaching peak HIV-1 production (Fig. 3).
To test whether HIV-1 infection affected cytokine expres-
sion in CHCD4 and KRCD4 cells, total cellular RNA was
isolated from infected cells 3 days after infection and the
expression and relative levels of mRNA for IL-2, IL-4, and
IFNg were tested by RT-PCR with uninfected cells serving
as controls (Fig. 1). The KRCD4 cells remained negative forFIG. 1. Expression of IFNg and HIV-1 envelope mRNA in uninfected
and HIV-1-infected CHCD4 and KRCD4 cells. Cells were infected by IFNg mRNA regardless of productive HIV-1 infection (lane
HIV-1 and RNA was isolated after 3 days as described under Materials 5). In contrast, the IFNg mRNA levels were higher in HIV-1-
and Methods. RT-PCR was performed using IFNg-specific primers. infected CHCD4 cells (lane 3) than in uninfected cells (lane
Lanes 7–15 are with b-actin primers and lanes 16–18 are with HIV-1
2). In agreement with IFNg mRNA analysis, supernatants ofenv-specific primers. Lane 1, mol wt marker; lane 2, uninfected CHCD4;
HIV-1-infected CHCD4 cells contained increased levels oflane 3, HIV-1-infected CHCD4; lane 4, uninfected KRCD4; lane 5, HIV-
1-infected KRCD4; lane 6, IFNg-positive control; lane 7, uninfected IFNg, but no IFNg was detected in the supernatants of
CHCD4; lane 8, HIV-1-infected CHCD4; lane 9, uninfected KRCD4; lane infected and uninfected KRCD4 cells (Table 2). IFNg was
10, HIV-1-infected KRCD4; lane 11, b-actin-positive control; lane 12, also upregulated after HIV-1 infection of other IFNg-produc-
uninfected CHCD4 without RT step; lane 13, HIV-1-infected CHCD4
ing cell lines (data not shown). HIV-1 infection had no effectwithout RT step; lane 14, uninfected KRCD4 without RT step; lane 15,
on the expression of IL-2 or IL-4 , which remained at theHIV-1-infected KRCD4 without RT step; lane 16, HIV-1-infected CHCD4;
lane 17, HIV-1-infected KRCD4; lane 18, HIV-1-positive control. background levels (Table 2) and no IL-2 or IL-4 mRNA was
detected by RT-PCR (not shown). These results indicate that
HIV-1 infection enhances the transcription and production of
nal transduction pathway through TCR remains func- IFNg in CHCD4 cells; however, the increased levels of the
tional (Saha et al., 1996). However, as reported previously endogenous and secreted cytokine appear to have no inhibi-
(Saha et al., 1996), none of these clones showed evi- tory effect on HIV-1 replication in these cells.
dence of either constitutive (Table 2) or inducible (not
shown) production of IL-2 or IL-4. Assay of cytokine
Effects of neutralization of IFNgmRNA production gave similar results to assay of protein
production (Fig. 1). CHCD4 (lane 2) but not KRCD4 (lane To determine whether endogenous IFNg plays any
4) cells constitutively produced IFNg mRNA, indicating role in HIV-1 infection in CHCD4 cells, we tested whether
that the absence of IFNg in KRCD4 supernatants (Table neutralizing antibodies against the cytokine modulate the
2) was due to a block of IFNg gene transcription rather course of HIV-1 replication in these cells. The IFNg-nega-
than to defective secretion of the cytokine by these cells. tive KRCD4 cells served as controls in these experi-
Neither clone constitutively expressed IL-2 or IL-4 mRNA ments. CHCD4 and KRCD4 cells were infected with HIV-
detectable by RT-PCR and expression was not induced 1, cultured in the presence of neutralizing anti-IFNg or
by PHA stimulation (data not shown). Thus, KRCD4 and control antibodies, and virus production was determined
CHCD4 have many common characteristics of HVS- by monitoring the RT activity in culture supernatants (Fig.
transformed CD4-positive T cells, except that CHCD4 2B). The presence of anti-IFNg antibodies had no effect
cells like most HVS-transformed T cells express endoge- on HIV-1 replication in KRCD4 cells. In contrast, addition
nous IFNg and KRCD4 cells do not. of these antibodies significantly inhibited virus replica-
tion in CHCD4 cells, particularly early after infection (Fig.
HIV-1 infection and effect on cytokine expression
2B). We have previously shown that polyclonal anti-IFNg
antibodies could effectively neutralize endogenously pro-HVS-transformed T cells are highly permissive to HIV-1
(Nick et al., 1993). We tested whether the observed differ- duced IFNg from HVS-transformed T cells (Saha et al.,
1996). The anti-IFNg at the dose used completely neutral-ences in IFNg expression by KRCD4 and CHCD4 cell lines
affect their susceptibility to a laboratory strain HTLV-IIIB ized IFNg present in culture supernatants of uninfected
CHCD4 cells; no IFNg was detected in these cultures(Figs. 1–3). HIV-1 efficiently replicated in both KRCD4 and
CHCD4 cells but virus infection was faster and production during initial 5–6 days, but cytokine levels gradually in-
creased thereafter (data not shown). Addition of freshwas higher in CHCD4 cells compared to KRCD4 cells (Fig.
2A). This may be because CHCD4 cells grew faster than anti-IFNg antibodies to HIV-1-infected CHCD4 cells at 4-
to 5-day intervals did not significantly change the patternKRCD4 cells (Fig. 3). However, as determined by RT-PCR
for HIV-1 V3-loop-specific mRNA, both cells expressed viral of HIV-1 replication obtained upon single anti-IFNg treat-
ment (data not shown) as other factors are also likely toenvelope-encoding mRNA 3 days after infection (Fig. 1,
lanes 16 and 17). Exposure to HIV-1 enhanced the prolifera- be involved in HIV-1 infection of these cells. Presence of
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FIG. 2. Infection of IFNg-producing (CHCD4) and IFNg-negative (KRCD4) cells by HIV-1 (A) and effects of anti-IFNg antibodies on HIV-1 production
(B). Cells were infected with HIV-1 and cultured in the presence or absence of anti-IFNg or control antibodies as described under Materials and
Methods. Virus production was monitored by supernatant reverse transcriptase (RT) assay at the times indicated.
anti-IFNg antibodies also significantly reduced the cyto- (Fig. 2B) and most of the cells eventually died, similar to
infected cells cultured in the absence of the antibodypathic effects of HIV-1 infection in CHCD4 cells but had
little or no effect on viability of infected KRCD4 cells (Fig. (Fig. 3). Treatment of uninfected CHCD4 cells with anti-
IFNg antibodies did not affect cell viability or growth rate3). In spite of the initial reduction in virus production,
HIV-1-infected CHCD4 cells cultured in the presence of as determined by trypan blue exclusion or [3H]thymidine
incorporation methods, respectively (data not shown), in-anti-IFNg continued to produce HIV-1 at lower levels
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caution in using IFNg for control of HIV-1 infection in
patients.
The studies reported here have been made possible
by the recent development of the efficient method of hu-
man T lymphocytes immortalization by HVS (reviewed
by Meinl et al., 1995). HVS-immortalized CD4-positive T
lymphocytes maintain normal T cell functions, including
their susceptibility to efficient HIV-1 infection (Nick et al.,
1993). Although the majority of the HVS-immortalized T
cell clones described thus far exhibit the Th1 profile,
including IFNg expression (De Carli et al., 1993; Saha et
al., 1996), we have identified one T cell clone, KRCD4,
which does not express IFNg (Table 1). Comparison of
the KRCD4 cells with the phenotypically similar but IFNg-
producing CD4/ T cell clones permitted us to determine
the role of endogenous IFNg in HIV-1 replication in this
model system. Three conclusions can be drawn from
these studies:
FIG. 3. Cytopathicity of HIV-1 infection and effect of anti-IFNg anti- (i) Contrary to its antiviral function during HIV-1 infec-
bodies in IFNg-producing (CHCD4) and IFNg-negative (KRCD4) cells. tion of macrophages (Fan et al., 1994), endogenous IFNg
Cells were infected as described in the legend to Fig. 2 and cell viability
does not inhibit HIV-1 infection and virus-mediated cytol-was determined by trypan blue exclusion at the times indicated.
ysis in cloned immortalized T lymphocytes. In fact, HIV-
1 replicated faster and to higher levels in IFNg-positive
dicating that inhibitory effect of the antibody on virus CHCD4 cells than in IFNg-negative KRCD4 cells (Fig. 2),
production is not due to antibody effects on target cell
physiology. The inhibitory effects of anti-IFNg antibodies
on HIV-1 replication were surprising in that they contra-
dict the postulated role of this cytokine in controlling HIV-
1 infection in T cells (Wong et al., 1988). To confirm this
phenomenon, we tested the effect of anti-IFNg antibod-
ies on HIV-1 replication in four other HVS-immortalized
T cell clones which constitutively express IFNg at the
levels comparable to that of CHCD4 cells (not shown).
As shown in Fig. 4, neutralization of IFNg significantly
inhibited HIV-1 production in a range of 37–56% in all
four CD4/ T cell clones. Like CHCD4 cells, although
HIV-1 production in these clones was not completely
arrested after anti-IFNg treatments, rate of virus replica-
tion (Fig. 4) and virus-induced cytolysis (data not shown)
were significantly inhibited. Together, these results dem-
onstrate that not only does endogenous IFNg fail to in-
hibit HIV-1 infection in HVS-immortalized CD4/ T cells,
but that it can significantly enhance virus replication and
its cytopathic effects in these cells.
DISCUSSION
The role of IFNg in HIV-1 infection of T cells is con-
troversial (Poli and Fauci, 1993). Using phenotypically FIG. 4. Inhibition of HIV-1 production in HVS-immortalized CD4/ T
cell clones by anti-IFNg antibodies. Cells were infected with HIV-1 assimilar HVS-immortalized T cell clones that differ in
described for the experiment described in the legend of Fig. 2. Anti-their expression of IFNg, we demonstrate here that
IFNg or control antibodies (5 mg/ml) were added to each clone asendogenous IFNg does not inhibit HIV-1 infection in
indicated. Culture supernatants were collected after 7 days and as-
T cells. To the contrary, our data suggest that endoge- sayed for HIV-p24 production. Percentage inhibition by anti-IFNg anti-
nous IFNg enhances HIV-1 replication and virus-medi- bodies was calculated in respect to virus production in the presence
of control antibodies.ated cytolysis in this model. These results recommend
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although this difference could also be attributed to the cells in vivo. The upregulation of IFNg production by HIV-
1 may contribute to HIV-1 pathogenesis in vivo in severalobserved variability among HVS-immortalized T cells in
HIV-1 replication (Nick et al., 1993). Other HVS-immortal- ways, including enhancement of T cell apoptosis (Fauci,
1993, Groux et al., 1992; Clerici et al., 1994), enhancedized CD4-positive T cell lines we established from PBL
of normal donors (Saha et al., 1996) which constitutively T cell death through stimulation of HIV-1 replication (Fig.
3), or deleterious effects in cellular gene expressionexpress IFNg are also susceptible to efficient HIV-1 in-
fection (data not shown). The lack of antiviral activity of (Balkwill and Burke, 1989; Atwood et al., 1994). IFNg may
also cause harmful effects indirectly, as proposed forIFNg in T lymphocytes observed here is consistent with
the study of Brinchmann et al. (1991) and Kinter et al. brain injury in AIDS through activation of brain macro-
phages (Gendelman et al., 1994). Although HVS-immor-(1995) but contradicts the results of Wong et al. (1988),
who showed that exogenous IFNg alone or in combina- talized T cells do not exactly represent primary T cells
and we cannot completely rule out the possibility thattion with TNF-a inhibited HIV-1 production in T cell lines
and primary T cells. One explanation of these discrepan- other HVS-specific or cellular genes differentially ex-
pressed in these cells influenced HIV-1 infection, ourcies is the use of unfractionated PBMC in the cited stud-
ies, a problem which has been alleviated here by em- results here demonstrate that at least in this system,
production of endogenous IFNg by CD4/ T cells en-ploying immortalized T cell clones differing primarily in
the expression of secretable IFNg. These results indicate hances HIV-1 replication.
In conclusion, our results add to the complex picturethat the anti-HIV-1 activity of IFNg is target cell depen-
dent; the cytokine efficiently blocks HIV-1 infection of of the roles of IFNg and other cytokines in HIV-1 infec-
tion. IFNg augments anti-viral activities of cytotoxic cellsmacrophages but has no such effect in T lymphocytes.
(ii) Surprisingly, instead of virus inhibition, endoge- (Lolli et al., 1994; Fauci, 1993) and protects monocyte/
macrophages against HIV infection (Gendelman et al.,nous IFNg-enhanced HIV-1 replication in our clones.
Neutralization of IFNg produced by CHCD4 cells (Fig. 1990). However, IFNg enhances HIV-1 replication in
CD4-positive T cells (Kinter et al., 1995, and this work).2B) and other CD4-positive clones (Fig. 4) significantly
reduced virus production. As expected, anti-IFNg anti- The contradictory roles of IFNg in HIV-1 infection in dif-
ferent cell types may explain the lack of success in onebodies had no effect on HIV-1 production in the cytokine-
negative KRCD4 cells (Fig. 2B). The mechanism of HIV- clinical trial of this cytokine in AIDS patients (Agosti et
al., 1992). Another study reported rapid exacerbation of1 enhancement by IFNg is unknown, but it may involve
some of the regulatory effects of interferon on the expres- Kaposi’s sarcoma in an AIDS patient on IFNg therapy
and the authors recommended caution in using IFNg insion of cellular genes (Samuel, 1991) or augmentation of
HIV-1 gp41 binding to cell surface, as shown using BJAB HIV-1-infected patients (Albrecht et al., 1994). The system
described here will permit detailed studies on the inter-cell line (Chen et al., 1993). Since HIV-1 replication invari-
ably results in cytolysis of primary T lymphocytes (Fauci, action between IFNg and HIV-1 in T lymphocytes with
the aim of uncoupling their reciprocal stimulation of ex-1993), our results also indicate that endogenous IFNg
may be responsible for enhanced lysis of CD4-positive pression.
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